(18)F-FDG PET/CT in sarcoidosis management: review and report of 20 cases.

(18)F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

(18)F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Abstract Text:

PURPOSE: To evaluate the interest of (18)F-fluoro-2-deoxy-D: -glucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) for diagnosis and therapeutic follow-up of patients with sarcoidosis. METHODS: Twenty consecutive patients with biopsy-proven sarcoidosis were retrospectively included, in particular, 13 and seven cases of thoracic and extra-thoracic sarcoidosis, respectively. All patients underwent (18)F-FDG PET/CT, and 12 of them also (67)Ga scintigraphy. Five patients were re-examined by (18)F-FDG PET/CT to assess response to corticosteroid (CS) treatment. RESULTS: Sensitivity of (18)F-FDG PET/CT in detecting active sarcoidosis localizations was determined considering only biopsy-proven sites. For thoracic, sinonasal, and pharyngo-laryngeal localizations, (18)F-FDG PET/CT sensitivity was 100%, 100%, and 80%, respectively. Overall sensitivity for all 36 biopsy-proven localizations improved from 78% to 87% after excluding skin involvement. Considering only the 12 patients who underwent both scintigraphic examinations, overall sensitivity of (67)Ga scintigraphy and (18)F-FDG PET/CT was 58% and 79%, respectively and improved to 67% and 86% after excluding all sites of skin involvement. To evaluate the efficacy of CS treatment, five enrolled patients underwent second (18)F-FDG PET/CT. Complete regression of all foci of pathological tracer uptake was showed in two cases, permitting CS withdrawal after 2 and 6 months. Improvement but incomplete regression of mediastino-pulmonary disease occurred in two patients treated with CS for 19 and 21 months. Disease progression was assessed in one patient treated with decreasing doses of CS during 16 months. CONCLUSION: (18)F-FDG PET/CT allows to obtain a complete morpho-functional cartography of inflammatory active localizations and to follow treatment efficacy in patients with sarcoidosis, particularly in atypical, complex, and multisystemic forms.

(18)F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

(18)F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: European journal of nuclear medicine and molecular

VOLUME: 35

Page Numbers: 1537-43

Journal Abbreviation: Eur. J. Nucl. Med. Mol. Imagin

ISSN: 1619-7070

DAY: 17

MONTH: 04

YEAR: 2008

(18)F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101140988

(18)F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: (18)F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for (18)F-FDG PET/CT in sarcoidosis management: review and report of 20 cases.

AFFILIATION: Service ORL, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, 67098, Strasbourg, France.

Country: Germany

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Eur J Nucl Med Mol Imaging

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases Related Publications

• (18)F-FDG PET/CT in sarcoidosis management: review and report of 20 cases.
• A multivariable model of clinical variables predicts advanced fibrosis in chronic hepatitis C.
• Adenovirus-based Prime-boost Immunization for Rapid Vaccination Against Anthrax.
• Assaying protein-DNA interactions in vivo and in vitro using chromatin immunoprecipitation and electrophoretic mobility shift assays.
• BK Virus as a Cofactor in the Etiology of Prostate Cancer in Its Early Stages.
• CT colonography versus colonoscopy for the detection of advanced neoplasia.
• Characterization of a permissive epitope insertion site in adenovirus hexon.
• Formation of a multiple protein complex on the adenovirus packaging sequence by the IVa2 protein.
• Identification of gangliosides GD1b and GT1b as receptors for BK virus.
• Inhibitory effect of gamma interferon on BK virus gene expression and replication.
• Keeping adenovirus away from the liver.
• Nurse-administered propofol sedation compared with midazolam and meperidine for EUS: a prospective, randomized trial.
• Nurse-administered propofol sedation for upper endoscopic ultrasonography.
• Presence of the adenovirus IVa2 protein at a single vertex of the mature virion.
• Screening, surveillance, and primary prevention for colorectal cancer: a review of the recent literature.
• Space-domain non-iterative approach for SPECT/CT systems considering attenuation and space-variant detector response.
• Survival of elderly persons undergoing colonoscopy: implications for colorectal cancer screening and surveillance.
• Ternary complex formation on the adenovirus packaging sequence by the IVa2 and L4 22-kilodalton proteins.
• Transforming growth factor-beta-mediated regulation of BK virus gene expression.